Acadia Pharmaceuticals | Der Umsatz



Sales Veränderung Datum
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
ALKERMES USD 306.5M 123.5M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Corcept Therapeutics USD 181.89M 656K 2024-12
Cytokinetics USD 16.93M 16.46M 2024-12
Eisai JPY 216.14B 20.15B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
Incyte USD 1.05B 128.7M 2025-03
J&J USD 21.89B 630M 2025-03
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Prothena USD 2.12M 1.15M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Acadia Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.